The Institutional Development Award (IDeA) program broadens the geographic distribution of funding for biomedical research. Delaware is one of 23 states and Puerto Rico that receive IDeA grants, which aim to build research capacities in states with historically low levels of funding from the National Institutes of Health.
Delaware has received more than $229 million in IDeA funding, making it a top recipient. The IDeA program has had a $484 million impact in the First State since 2000, according to a Batelle Technology Partnership Practice study.
How it Works
The IDeA program has three components:
COBRE (Centers of Biomedical Research Excellence) provide support for a multidisciplinary center led by a NIH-funded investigator with critical expertise related to a particular area of focus.
INBRE (IDeA Networks of Biomedical Research) focuses on expanding and strengthening the pipeline of biomedical researchers by funding infrastructure, faculty development, mentorship and other resources.
The Clinical and Translational Research initiative encourages applications from IDeA states to develop infrastructure and capacity to conduct clinical and translational research on diseases that affect medically underserved populations and/or diseases prevalent in IDeA states. It further provides for mentoring and career development activities in clinical and translational research.
Delaware is one of 23 states and Puerto Rico that receive IDeA grants, which aim to build research capacities in states with historically low levels of funding from the National Institutes of Health.
In addition to DCMR, Delaware also is home to six COBREs focusing on sickle cell research, cardiovascular research and pediatric research, among others.
- Discovery of Chemical Probes and Therapeutic Leads– PI: Joseph Fox (Grant number: 5P20GM104316-03)
- The Delaware Center for Neuroscience Research– PI: Melissa Harrington (Grant number: 5P20GM103653-03)
- Center for Cardiovascular Research– PI: David Edwards (Grant number: 1P20GM113125-01)
- Molecular Design of Advanced Biomaterials– PI: Tatyana Polenova (Grant number: P30GM110758)
- Nemours Center for Pediatric Research– PI: Thomas Shaffer (Grant number: 5P30GM114736-02)
- The Delaware Comprehensive Sickle Cell Research Center– PI: Marie Stuart (Grant number P20GM109021)
Delaware CTR ACCEL
The Delaware CTR ACCEL is focused on developing the infrastructure to build a sustainable clinical and translational research capability in the state. Stuart Binder-Macleod, UD serves as PI of this two-state initiative, with UD, Christiana Care, Nemours and the Medical University of South Carolina as partner institutions. (Grant number: U54-GM104941)